Natalia Rachwał
Research Subjects
Natalia Rachwał has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
- Adrian Kubicki
Czerniakowski Hospital in Warsaw, Poland
9 shared publications - Adrianna Jaślikowska
Military Clinical Hospital with the Polyclinic SPZOZ in Lublin, Poland
9 shared publications - Dominika Grzybowska
St. Luke's Provincial Hospital in Tarnow, Poland
9 shared publications - Jakub Rzeszutek
St. Luke's Provincial Hospital in Tarnow, Poland
9 shared publications - Kamil Idzik
Murcki Hospital in Katowice, Poland
9 shared publications - Michał Kurnik
Megrez Provincial Multi-Specialist Hospital in Tychy, Poland
9 shared publications
Latest Publications
- Open Access
- 29 September 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 95, 73660
Obesity and depression - a bidirectional relationship and clinical implications
Background: Obesity has become a global civilization-related disease and constitutes an independent risk factor for numerous somatic disorders. Obesity can contribute to depression through low self-esteem, body image concerns, and stigmatization, while depression and chronic stress may promote obesity through emotional eating and binge eating. Both conditions share biological mechanisms, including HPA axis dysregulation, elevated cortisol levels, and chronic inflammation. Effective management requires an interdisciplinary approach that combines weight-loss interventions with psychological treatment. Weight reduction is associated with improved mood and quality of life. Aim: The aim of this narrative review is to analyze and synthesize the current state of knowledge regarding the relationship between obesity and depression. The paper seeks to identify the biological and psychological mechanisms linking both conditions, as well as to assess the impact of obesity on the risk of depression and, conversely, the impact of depressive disorders on the development and course of obesity. Material and methods: A literature review of scientific publications available in databases (including Google Scholar) was conducted, analyzing data on adolescents and adults with respect to pathophysiological and behavioral mechanisms. The review includes 24 articles published between 2006 and 2025. Results: Individuals with obesity have a 55% higher risk of developing depression, whereas patients with depression are 58% more likely to develop obesity. The prevalence of depression in the population of individuals with obesity is increased, and a modifying effect of sex is observed. Key mechanisms include dysregulation of the HPA axis, chronic inflammation, and disturbances in neurotransmission. Conclusions: Effective treatment requires an integrated approach combining weight reduction with psychological interventions. Treatment of obesity may lead to an improvement in mood.
- 29 September 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 95, 73660
Open AccessObesity and depression - a bidirectional relationship and clinical implications
Background: Obesity has become a global civilization-related disease and constitutes an independent risk factor for numerous somatic disorders. Obesity can contribute to depression through low self-esteem, body image concerns, and stigmatization, while depression and chronic stress may promote obesity through emotional eating and binge eating. Both conditions share biological mechanisms, including HPA axis dysregulation, elevated cortisol levels, and chronic inflammation. Effective management requires an interdisciplinary approach that combines weight-loss interventions with psychological treatment. Weight reduction is associated with improved mood and quality of life. Aim: The aim of this narrative review is to analyze and synthesize the current state of knowledge regarding the relationship between obesity and depression. The paper seeks to identify the biological and psychological mechanisms linking both conditions, as well as to assess the impact of obesity on the risk of depression and, conversely, the impact of depressive disorders on the development and course of obesity. Material and methods: A literature review of scientific publications available in databases (including Google Scholar) was conducted, analyzing data on adolescents and adults with respect to pathophysiological and behavioral mechanisms. The review includes 24 articles published between 2006 and 2025. Results: Individuals with obesity have a 55% higher risk of developing depression, whereas patients with depression are 58% more likely to develop obesity. The prevalence of depression in the population of individuals with obesity is increased, and a modifying effect of sex is observed. Key mechanisms include dysregulation of the HPA axis, chronic inflammation, and disturbances in neurotransmission. Conclusions: Effective treatment requires an integrated approach combining weight reduction with psychological interventions. Treatment of obesity may lead to an improvement in mood.
- Open Access
- 22 September 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 75, 75776
The Ketogenic Diet in Depression: Potential Biological Mechanisms and Current Clinical Evidence - A Narrative Review
Background: Depression is a multifactorial psychiatric disorder whose underlying mechanisms extend beyond classical neurotransmitter abnormalities and involve metabolic, inflammatory and neurobiological disturbances. Recent evidence suggests that the pathophysiology of depression involves neuroinflammation, mitochondrial dysfunction, oxidative stress, neurotransmitter dysregulation and alterations in the gut–brain axis. These findings have contributed to growing interest in the field of metabolic psychiatry. Aim: The aim of this review was to summarize the current evidence regarding the potential effects of the ketogenic diet on depressive symptoms and to discuss the biological mechanisms that may underlie these effects. Material and methods: A literature was conducted using PubMed and Google Scholar. The review was based primarily on systematic reviews, meta-analyses, clinical trials, case reports and experimental studies addressing depression, ketogenic diet and metabolic psychiatry. Results: The available evidence suggests that the ketogenic diet may contribute to the alleviation of depressive symptoms through the reduction of neuroinflammation and oxidative stress, improvement of mitochondrial function, modulation of neurotransmitter systems and regulation of the gut–brain axis. Preliminary clinical studies have reported improvements in depressive symptoms among patients following ketogenic interventions. However, the available studies are limited by small sample sizes and short follow-up periods. Conclusions: The ketogenic diet may represent a promising adjunctive intervention for the management of depressive symptoms. Nevertheless, the current evidence remains insufficient to recommend it as a standard treatment for depression. Further large-scale, long-term randomized controlled trials are required to establish its efficacy and safety in patients with depressive disorders.
- 22 September 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 75, 75776
Open AccessThe Ketogenic Diet in Depression: Potential Biological Mechanisms and Current Clinical Evidence - A Narrative Review
Background: Depression is a multifactorial psychiatric disorder whose underlying mechanisms extend beyond classical neurotransmitter abnormalities and involve metabolic, inflammatory and neurobiological disturbances. Recent evidence suggests that the pathophysiology of depression involves neuroinflammation, mitochondrial dysfunction, oxidative stress, neurotransmitter dysregulation and alterations in the gut–brain axis. These findings have contributed to growing interest in the field of metabolic psychiatry. Aim: The aim of this review was to summarize the current evidence regarding the potential effects of the ketogenic diet on depressive symptoms and to discuss the biological mechanisms that may underlie these effects. Material and methods: A literature was conducted using PubMed and Google Scholar. The review was based primarily on systematic reviews, meta-analyses, clinical trials, case reports and experimental studies addressing depression, ketogenic diet and metabolic psychiatry. Results: The available evidence suggests that the ketogenic diet may contribute to the alleviation of depressive symptoms through the reduction of neuroinflammation and oxidative stress, improvement of mitochondrial function, modulation of neurotransmitter systems and regulation of the gut–brain axis. Preliminary clinical studies have reported improvements in depressive symptoms among patients following ketogenic interventions. However, the available studies are limited by small sample sizes and short follow-up periods. Conclusions: The ketogenic diet may represent a promising adjunctive intervention for the management of depressive symptoms. Nevertheless, the current evidence remains insufficient to recommend it as a standard treatment for depression. Further large-scale, long-term randomized controlled trials are required to establish its efficacy and safety in patients with depressive disorders.
- Open Access
- 31 August 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 95, 73641
Emerging Biologic Strategies in Crohn’s Disease
Crohn’s disease is an inflammatory bowel disease, which substantially impairs patients’ quality of life. Despite ongoing advances, effective long-term management remains challenging in many cases. Conventional therapies are often associated with significant adverse effects and limited suitability for sustained use. This review provides an overview of the current landscape of novel biological therapeutics and their molecular targets. Several biologic therapies are already well established in clinical practice. Among them, IL-23 inhibitors stand out due to their high efficacy in both inducing and maintaining remission. Agents targeting the TL1A pathway, as well as human amniotic epithelial cells have shown promising early results and are currently under further investigation in clinical trials. Nevertheless, discontinuation of some biologics trials proves that not all theoretically attractive targets translate into meaningful clinical outcomes. Importantly, variability in efficacy can be observed even within the same class of drugs. This is exemplified by the success of upadacitinib in contrast to tofacitinib, which did not meet primary endpoints and was not further developed for this indication. Overall, these findings highlight both the progress achieved and the ongoing challenges in optimizing targeted therapies for Crohn’s disease.
- 31 August 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 95, 73641
Open AccessEmerging Biologic Strategies in Crohn’s Disease
Crohn’s disease is an inflammatory bowel disease, which substantially impairs patients’ quality of life. Despite ongoing advances, effective long-term management remains challenging in many cases. Conventional therapies are often associated with significant adverse effects and limited suitability for sustained use. This review provides an overview of the current landscape of novel biological therapeutics and their molecular targets. Several biologic therapies are already well established in clinical practice. Among them, IL-23 inhibitors stand out due to their high efficacy in both inducing and maintaining remission. Agents targeting the TL1A pathway, as well as human amniotic epithelial cells have shown promising early results and are currently under further investigation in clinical trials. Nevertheless, discontinuation of some biologics trials proves that not all theoretically attractive targets translate into meaningful clinical outcomes. Importantly, variability in efficacy can be observed even within the same class of drugs. This is exemplified by the success of upadacitinib in contrast to tofacitinib, which did not meet primary endpoints and was not further developed for this indication. Overall, these findings highlight both the progress achieved and the ongoing challenges in optimizing targeted therapies for Crohn’s disease.
- Open Access
- 21 July 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 95, 73069
Weighted Blankets as a Non-Pharmacological Intervention for Sleep, Mental and Neurodevelopmental Disorders: A Narrative Review
Background: Weighted blankets are a non-pharmacological intervention based on deep pressure stimulation (DPS) that has gained increasing popularity as a supportive method for improving sleep, reducing anxiety, and enhancing daily functioning in individuals with mental and neurodevelopmental disorders. Despite their widespread use in both clinical and home settings, the evidence regarding their effectiveness remains inconsistent. Results: Available evidence suggests that weighted blankets are generally safe and well tolerated. Some studies indicate improvements in subjective sleep quality, insomnia severity, anxiety symptoms, and daytime functioning, particularly among individuals with insomnia co-occurring with anxiety or psychiatric disorders. However, findings regarding objective sleep parameters remain inconsistent. Evidence supporting the use of weighted blankets in ASD is limited, whereas preliminary findings in ADHD suggest potential benefits for sleep outcomes. Proposed mechanisms include modulation of autonomic nervous system activity, increased melatonin secretion, and effects on sensory processing, although these hypotheses require further confirmation. Conclusions: Current evidence does not support the routine use of weighted blankets as a standalone therapeutic intervention. Nevertheless, they may represent a safe and accessible adjunctive strategy for selected patients, particularly those experiencing insomnia and anxiety. Further high-quality studies employing objective outcome measures are needed to clarify their clinical effectiveness and mechanisms of action
- 21 July 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 95, 73069
Open AccessWeighted Blankets as a Non-Pharmacological Intervention for Sleep, Mental and Neurodevelopmental Disorders: A Narrative Review
Background: Weighted blankets are a non-pharmacological intervention based on deep pressure stimulation (DPS) that has gained increasing popularity as a supportive method for improving sleep, reducing anxiety, and enhancing daily functioning in individuals with mental and neurodevelopmental disorders. Despite their widespread use in both clinical and home settings, the evidence regarding their effectiveness remains inconsistent. Results: Available evidence suggests that weighted blankets are generally safe and well tolerated. Some studies indicate improvements in subjective sleep quality, insomnia severity, anxiety symptoms, and daytime functioning, particularly among individuals with insomnia co-occurring with anxiety or psychiatric disorders. However, findings regarding objective sleep parameters remain inconsistent. Evidence supporting the use of weighted blankets in ASD is limited, whereas preliminary findings in ADHD suggest potential benefits for sleep outcomes. Proposed mechanisms include modulation of autonomic nervous system activity, increased melatonin secretion, and effects on sensory processing, although these hypotheses require further confirmation. Conclusions: Current evidence does not support the routine use of weighted blankets as a standalone therapeutic intervention. Nevertheless, they may represent a safe and accessible adjunctive strategy for selected patients, particularly those experiencing insomnia and anxiety. Further high-quality studies employing objective outcome measures are needed to clarify their clinical effectiveness and mechanisms of action
- Open Access
- 12 July 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 62, 73379
The Use of Wearable Technology in Monitoring Physical Activity and Training: A Systematic Review
Introduction and purpose: Wearable technologies have become widely adopted tools for monitoring physical activity and optimizing athletic training, yet comprehensive evaluations of their accuracy and effectiveness remain fragmented. This systematic review synthesizes evidence on wearable technology in physical activity monitoring and sport-specific training. Materials and methods: A systematic search of PubMed, Embase, Web of Science, SPORTDiscus, and CENTRAL was conducted for studies published between 2015 and 2025, following PRISMA 2020 guidelines. Systematic reviews, meta-analyses, and primary validation studies were synthesized. Brief description of the state of knowledge: Step counting reached acceptable accuracy in leading consumer devices (mean absolute percentage error below 25%), and optical heart rate sensors performed well at rest and moderate intensity (MAPE below 10%). Energy expenditure estimation remained inaccurate across all devices (MAPE exceeding 30%). An umbrella review of 39 systematic reviews found that 79% of physical activity analyses favored wearable interventions. A meta-analysis of 23 trials involving 4,566 older adults reported significant improvements in daily step counts and physical activity time, whereas no significant effects were found in youth populations. Summary: Wearable devices offer acceptable accuracy for step counting and heart rate but not energy expenditure. Standardized validation protocols, algorithmic transparency, and long-term effectiveness studies are needed to maximize clinical and sporting utility.
- 12 July 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 62, 73379
Open AccessThe Use of Wearable Technology in Monitoring Physical Activity and Training: A Systematic Review
Introduction and purpose: Wearable technologies have become widely adopted tools for monitoring physical activity and optimizing athletic training, yet comprehensive evaluations of their accuracy and effectiveness remain fragmented. This systematic review synthesizes evidence on wearable technology in physical activity monitoring and sport-specific training. Materials and methods: A systematic search of PubMed, Embase, Web of Science, SPORTDiscus, and CENTRAL was conducted for studies published between 2015 and 2025, following PRISMA 2020 guidelines. Systematic reviews, meta-analyses, and primary validation studies were synthesized. Brief description of the state of knowledge: Step counting reached acceptable accuracy in leading consumer devices (mean absolute percentage error below 25%), and optical heart rate sensors performed well at rest and moderate intensity (MAPE below 10%). Energy expenditure estimation remained inaccurate across all devices (MAPE exceeding 30%). An umbrella review of 39 systematic reviews found that 79% of physical activity analyses favored wearable interventions. A meta-analysis of 23 trials involving 4,566 older adults reported significant improvements in daily step counts and physical activity time, whereas no significant effects were found in youth populations. Summary: Wearable devices offer acceptable accuracy for step counting and heart rate but not energy expenditure. Standardized validation protocols, algorithmic transparency, and long-term effectiveness studies are needed to maximize clinical and sporting utility.
- Open Access
- 11 July 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 62, 73060
The Current State of Knowledge on Magnesium’s Influence on Sleep Health: A Narrative Review
Background: Sleep is a fundamental biological process essential for physical and mental health. Adequate sleep supports metabolic balance, immune function, cognitive performance, and emotional regulation. Chronic sleep insufficiency, however, is a major health burden. There is accumulating evidence to suggest that low magnesium intake and subclinical magnesium deficiency may be associated with poor sleep quality and an increased risk of insomnia. Aim: The aim of this study was to analyze the mechanisms of magnesium action in the body that may influence our sleep health and summarise the available scientific literature on the subject. Materials and methods: A narrative review was performed using PubMed and Google Scholar databases. In total, 29 publications were included, focusing on systematic reviews, meta-analyses, and randomized controlled trials. Results: The reviewed studies show an association between higher magnesium levels and better sleep efficiency. Clinical trials reported modest improvements in sleep quality among groups that either supplemented or had higher dietary intake of Mg compared to placebo. The limitations of most presented trials include relatively small populations and short durations. Conclusions: The reviewed evidence indicates that low magnesium status is associated with fragmented or nonrestorative sleep, while magnesium supplementation may provide modest improvements in sleep outcomes. Future work should clarify optimal dosages and formulations and identify which populations (e.g. older adults, individuals experiencing stress, or those with inflammatory conditions) benefit the most from Mg supplementation.
- 11 July 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 62, 73060
Open AccessThe Current State of Knowledge on Magnesium’s Influence on Sleep Health: A Narrative Review
Background: Sleep is a fundamental biological process essential for physical and mental health. Adequate sleep supports metabolic balance, immune function, cognitive performance, and emotional regulation. Chronic sleep insufficiency, however, is a major health burden. There is accumulating evidence to suggest that low magnesium intake and subclinical magnesium deficiency may be associated with poor sleep quality and an increased risk of insomnia. Aim: The aim of this study was to analyze the mechanisms of magnesium action in the body that may influence our sleep health and summarise the available scientific literature on the subject. Materials and methods: A narrative review was performed using PubMed and Google Scholar databases. In total, 29 publications were included, focusing on systematic reviews, meta-analyses, and randomized controlled trials. Results: The reviewed studies show an association between higher magnesium levels and better sleep efficiency. Clinical trials reported modest improvements in sleep quality among groups that either supplemented or had higher dietary intake of Mg compared to placebo. The limitations of most presented trials include relatively small populations and short durations. Conclusions: The reviewed evidence indicates that low magnesium status is associated with fragmented or nonrestorative sleep, while magnesium supplementation may provide modest improvements in sleep outcomes. Future work should clarify optimal dosages and formulations and identify which populations (e.g. older adults, individuals experiencing stress, or those with inflammatory conditions) benefit the most from Mg supplementation.
- Open Access
- 26 June 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 60
Psychological Consequences of Understaffing in Healthcare Systems: A Narrative Review
Background: Understaffing in healthcare occurs when the number of available workers is insufficient to meet patient care and organizational demands. Driven by population aging, chronic disease prevalence, workforce migration, inadequate planning, and the COVID-19 pandemic, staff shortages have become a major global challenge. Understaffing increases workload, time pressure, and emotional demands, raising the risk of serious psychological consequences affecting both worker well-being and quality of care. Aim: The aim of this narrative review was to examine the psychological consequences of understaffing, analyze its impact on the mental health of healthcare professionals, and identify potential preventive strategies. Material and Methods: A narrative review was conducted using the PubMed, Scopus, and Google Scholar databases. Peer-reviewed articles addressing the psychological outcomes of understaffing among healthcare workers were identified using predefined keywords, screened by title and abstract, reviewed in full text, and analyzed thematically. Results: The literature consistently identified burnout—comprising emotional exhaustion, depersonalization, and reduced personal accomplishment—as the most prominent psychological consequence of understaffing. Staff shortages were also linked to stress, anxiety, depression, sleep deprivation, moral distress, and compassion fatigue. At the system level, understaffing contributed to absenteeism, turnover intention, medical errors, lower quality of care, and patient dissatisfaction, creating a self-perpetuating cycle. Conclusions: Understaffing is both an organizational and public health concern with serious psychological consequences for healthcare professionals. Effective staffing policies, organizational and leadership support, mental health services, resilience programs, and improved work-life balance are essential for protecting worker well-being and ensuring sustainable healthcare delivery.
- 26 June 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 60
Open AccessPsychological Consequences of Understaffing in Healthcare Systems: A Narrative Review
Background: Understaffing in healthcare occurs when the number of available workers is insufficient to meet patient care and organizational demands. Driven by population aging, chronic disease prevalence, workforce migration, inadequate planning, and the COVID-19 pandemic, staff shortages have become a major global challenge. Understaffing increases workload, time pressure, and emotional demands, raising the risk of serious psychological consequences affecting both worker well-being and quality of care. Aim: The aim of this narrative review was to examine the psychological consequences of understaffing, analyze its impact on the mental health of healthcare professionals, and identify potential preventive strategies. Material and Methods: A narrative review was conducted using the PubMed, Scopus, and Google Scholar databases. Peer-reviewed articles addressing the psychological outcomes of understaffing among healthcare workers were identified using predefined keywords, screened by title and abstract, reviewed in full text, and analyzed thematically. Results: The literature consistently identified burnout—comprising emotional exhaustion, depersonalization, and reduced personal accomplishment—as the most prominent psychological consequence of understaffing. Staff shortages were also linked to stress, anxiety, depression, sleep deprivation, moral distress, and compassion fatigue. At the system level, understaffing contributed to absenteeism, turnover intention, medical errors, lower quality of care, and patient dissatisfaction, creating a self-perpetuating cycle. Conclusions: Understaffing is both an organizational and public health concern with serious psychological consequences for healthcare professionals. Effective staffing policies, organizational and leadership support, mental health services, resilience programs, and improved work-life balance are essential for protecting worker well-being and ensuring sustainable healthcare delivery.
- Open Access
- 26 June 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 60
Emergency Department Utilization According to Patient Age and Type of Presenting Complaints: A Narrative Review
Background: The number of patients presenting to hospital emergency departments (EDs) has been consistently increasing. Patients present with a wide spectrum of complaints, from specific symptoms directing diagnostic evaluation to entirely non-specific ones, and their clinical relevance varies with age. Aim: To summarize and compare presenting complaints reported by ED patients across age groups and to discuss their association with clinical outcomes. Material and methods: A literature search was performed in PubMed (MEDLINE) to identify publications on presenting complaints in ED patients. Case reports, case series, letters, editorials, and commentaries were excluded. Only English-language full-text studies were included; no date restrictions were applied. Results: The spectrum of presenting complaints is broadly similar across age groups, whereas their frequency differs substantially with age. ED utilization is highest at the extremes of age. In children, infectious complaints (fever, respiratory and gastrointestinal symptoms) and injuries dominate, and hospitalization rates are low. In adults, the spectrum is more heterogeneous, and many patients are discharged with a symptom-based rather than definitive diagnosis. In older adults, non-specific complaints such as fatigue, weakness, and confusion become one of the most common reasons for presentation; their proportion rises with age and they are associated with higher hospitalization and mortality rates than complaints traditionally regarded as more urgent. The same complaint may carry a markedly different prognosis depending on age. Conclusions: Both the frequency of presenting complaints and their clinical consequences in the ED are strongly age-dependent. The presenting complaint should be interpreted together with patient age, as a complementary component of risk assessment. Older patients with non-specific complaints warrant particular attention as a group at increased risk of adverse outcomes.
- 26 June 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 60
Open AccessEmergency Department Utilization According to Patient Age and Type of Presenting Complaints: A Narrative Review
Background: The number of patients presenting to hospital emergency departments (EDs) has been consistently increasing. Patients present with a wide spectrum of complaints, from specific symptoms directing diagnostic evaluation to entirely non-specific ones, and their clinical relevance varies with age. Aim: To summarize and compare presenting complaints reported by ED patients across age groups and to discuss their association with clinical outcomes. Material and methods: A literature search was performed in PubMed (MEDLINE) to identify publications on presenting complaints in ED patients. Case reports, case series, letters, editorials, and commentaries were excluded. Only English-language full-text studies were included; no date restrictions were applied. Results: The spectrum of presenting complaints is broadly similar across age groups, whereas their frequency differs substantially with age. ED utilization is highest at the extremes of age. In children, infectious complaints (fever, respiratory and gastrointestinal symptoms) and injuries dominate, and hospitalization rates are low. In adults, the spectrum is more heterogeneous, and many patients are discharged with a symptom-based rather than definitive diagnosis. In older adults, non-specific complaints such as fatigue, weakness, and confusion become one of the most common reasons for presentation; their proportion rises with age and they are associated with higher hospitalization and mortality rates than complaints traditionally regarded as more urgent. The same complaint may carry a markedly different prognosis depending on age. Conclusions: Both the frequency of presenting complaints and their clinical consequences in the ED are strongly age-dependent. The presenting complaint should be interpreted together with patient age, as a complementary component of risk assessment. Older patients with non-specific complaints warrant particular attention as a group at increased risk of adverse outcomes.
- Open Access
- 26 June 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 60
Safety of Psychiatric Medications in Glaucoma. A Review of Current Medical Knowledge
Glaucoma is a leading cause of irreversible blindness, and psychiatric patients are at increased risk of ocular adverse effects from pharmacotherapy; this review summarizes the safety of psychiatric medications with respect to glaucoma type, including open-angle and angle-closure forms. A search of PubMed, Scopus, and Web of Science covering studies from 2020 to 2026, including observational studies, meta-analyses, and systematic reviews, assessed associations between psychiatric drugs, glaucoma risk, and intraocular pressure. Selective serotonin reuptake inhibitors demonstrate a favorable profile in open-angle glaucoma, with modest intraocular pressure reduction and decreased risk, whereas benzodiazepines are associated with increased glaucoma risk, particularly in angle-closure glaucoma. Topiramate shows a strong association with acute angle-closure glaucoma, while tricyclic antidepressants, despite anticholinergic effects, do not consistently increase glaucoma risk. Antipsychotics, especially olanzapine, may precipitate acute angle closure, whereas lithium appears neutral or potentially protective. Overall, psychiatric medications exhibit heterogeneous ophthalmic safety, and particular caution is warranted with topiramate and benzodiazepines in patients with narrow angles or angle-closure glaucoma, alongside regular ophthalmologic monitoring.
- 26 June 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 60
Open AccessSafety of Psychiatric Medications in Glaucoma. A Review of Current Medical Knowledge
Glaucoma is a leading cause of irreversible blindness, and psychiatric patients are at increased risk of ocular adverse effects from pharmacotherapy; this review summarizes the safety of psychiatric medications with respect to glaucoma type, including open-angle and angle-closure forms. A search of PubMed, Scopus, and Web of Science covering studies from 2020 to 2026, including observational studies, meta-analyses, and systematic reviews, assessed associations between psychiatric drugs, glaucoma risk, and intraocular pressure. Selective serotonin reuptake inhibitors demonstrate a favorable profile in open-angle glaucoma, with modest intraocular pressure reduction and decreased risk, whereas benzodiazepines are associated with increased glaucoma risk, particularly in angle-closure glaucoma. Topiramate shows a strong association with acute angle-closure glaucoma, while tricyclic antidepressants, despite anticholinergic effects, do not consistently increase glaucoma risk. Antipsychotics, especially olanzapine, may precipitate acute angle closure, whereas lithium appears neutral or potentially protective. Overall, psychiatric medications exhibit heterogeneous ophthalmic safety, and particular caution is warranted with topiramate and benzodiazepines in patients with narrow angles or angle-closure glaucoma, alongside regular ophthalmologic monitoring.
- Open Access
- 30 May 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 56
Recovery of the Hypothalamic-Pituitary-Testicular Axis After Anabolic-Androgenic Steroid Cessation. A Review of Therapeutic Options and the Fundamental Role of the Primary Care Physician in Harm Reduction.
The recreational abuse of anabolic-androgenic steroids (AAS) is a major public health concern among amateur athletes. Supraphysiologic androgen exposure disrupts the hypothalamic-pituitary-testicular axis, inducing Anabolic Steroid-Induced Hypogonadism (ASIH). This study evaluates endocrine and spermatogenesis recovery timelines, reviews pharmacological interventions, and defines the role of primary care physicians (PCPs) in harm reduction. Based on a comprehensive literature review from 1990 to 2025, twenty key publications were analyzed. Results indicate that spontaneous axis recovery is prolonged. While serum testosterone normalizes within 3 months post-cessation, full spermatogenesis recovery averages 12 months. Up to 27 percent of former users exhibit persistent hypogonadism and psychiatric withdrawal symptoms years later. Combined off-label pharmacotherapy using human chorionic gonadotropin (hCG) alongside selective estrogen receptor modulators (SERMs) accelerates testosterone restitution and restores fertility in over 70 percent of azoospermic patients. General practitioners occupy the critical frontline to mitigate life-threatening complications through clinical surveillance.
- 30 May 2026
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 56
Open AccessRecovery of the Hypothalamic-Pituitary-Testicular Axis After Anabolic-Androgenic Steroid Cessation. A Review of Therapeutic Options and the Fundamental Role of the Primary Care Physician in Harm Reduction.
The recreational abuse of anabolic-androgenic steroids (AAS) is a major public health concern among amateur athletes. Supraphysiologic androgen exposure disrupts the hypothalamic-pituitary-testicular axis, inducing Anabolic Steroid-Induced Hypogonadism (ASIH). This study evaluates endocrine and spermatogenesis recovery timelines, reviews pharmacological interventions, and defines the role of primary care physicians (PCPs) in harm reduction. Based on a comprehensive literature review from 1990 to 2025, twenty key publications were analyzed. Results indicate that spontaneous axis recovery is prolonged. While serum testosterone normalizes within 3 months post-cessation, full spermatogenesis recovery averages 12 months. Up to 27 percent of former users exhibit persistent hypogonadism and psychiatric withdrawal symptoms years later. Combined off-label pharmacotherapy using human chorionic gonadotropin (hCG) alongside selective estrogen receptor modulators (SERMs) accelerates testosterone restitution and restores fertility in over 70 percent of azoospermic patients. General practitioners occupy the critical frontline to mitigate life-threatening complications through clinical surveillance.